ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global CRISPR and CRISPR-Associated (Cas) Genes Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
Published Date: June 2025
|
Report Code: QYRE-Auto-39I6706
Home | Market Reports | Science| Biological Sciences
China CRISPR and CRISPR Associated Cas Genes Market Report Forecast 2021 2027
BUY CHAPTERS

Global CRISPR and CRISPR-Associated (Cas) Genes Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031

Code: QYRE-Auto-39I6706
Report
June 2025
Pages:134
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Thermo Fisher Scientific
Editas Medicine
Caribou Biosciences
CRISPR Therapeutics
Intellia Therapeutics Inc
CELLECTIS
Horizon Discovery Plc
Sigma-aldrich
Precision Biosciences
GenScript
Sangamo BioSciences, Inc.
Lonza Group Limited
Integrated DNA Technologies
New England Biolabs
Origene Technologies

CRISPR and CRISPR-Associated (Cas) Genes Market Size

In 2024, the global market size of CRISPR and CRISPR-Associated (Cas) Genes was estimated to be worth US$ 2399 million and is forecast to reach approximately US$ 16260 million by 2031 with a CAGR of 31.9% during the forecast period 2025-2031.

CRISPR and CRISPR-Associated (Cas) Genes Market

CRISPR and CRISPR-Associated (Cas) Genes Market

This report studies the CRISPR And CRISPR-Associated (Cas) Genes market.
Clustered regularly interspaced short palindromic repeats (CRISPR) are segments of prokaryotic DNA containing short repetitions of base sequences. Each repetition is followed by short segments of "spacer DNA" from previous exposures to a bacteriophage virus or plasmid.
The CRISPR/Cas system is a prokaryotic immune system that confers resistance to foreign genetic elements such as those present within plasmids and phages, and provides a form of acquired immunity. CRISPR associated proteins (Cas) use the CRISPR spacers to recognize and cut these exogenous genetic elements in a manner analogous to RNA interference in eukaryotic organisms. CRISPRs are found in approximately 40% of sequenced bacterial genomes and 90% of sequenced archaea.
Cas9 was the first nuclease discovered, followed by Cpf1, which was discovered in the CRISPR/Cpf1 system of Francisella novicida. Other such systems are thought to exist. CRISPR/Editas Medicinec2 from the bacterium Leptotrichia shahii is RNA-guided CRISPR system that targets RNA rather than DNA, and can either cleave single-stranded RNA targets or knock them down.
By delivering the Cas9 nuclease complexed with a synthetic guide RNA (gRNA) into a cell, the cell"s genome can be cut at a desired location, allowing existing genes to be removed and/or new ones added. The Cas9-gRNA complex corresponds with the CAS III crRNA complex in the above diagram. CRISPR/Cas genome editing techniques have many potential applications, including altering the germline of humans, animals, and food crops. The use of CRISPR Cas9-gRNA complex for genome editing was the AAAS"s choice for breakthrough of the year in 2015. Bioethical concerns have been expressed about the prospect of using this nascent biotechnology for editing the human germline.
Thermo Fisher Scientific, Editas Medicine, Caribou Biosciences, CRISPR therapeutics and Intellia therapeutics, Inc. are the top 5 players of CRISPR and CRISPR-Associated (Cas) Genes, with about 63% market shares.
CRISPR And CRISPR-Associated (Cas) Genes industry is relatively concentrated, manufacturers are mostly in the Europe and North America. Among them, North America region accounted for more than 45% of the total market of global CRISPR And CRISPR-Associated (Cas) Genes.

Report Scope

This report aims to provide a comprehensive presentation of the global market for CRISPR and CRISPR-Associated (Cas) Genes, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding CRISPR and CRISPR-Associated (Cas) Genes.
The CRISPR and CRISPR-Associated (Cas) Genes market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global CRISPR and CRISPR-Associated (Cas) Genes market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the CRISPR and CRISPR-Associated (Cas) Genes companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Market Segmentation

Scope of CRISPR and CRISPR-Associated (Cas) Genes Market Report

Report Metric Details
Report Name CRISPR and CRISPR-Associated (Cas) Genes Market
CAGR 31.9%
Segment by Type
  • Genome Editing
  • Genetic engineering
  • gRNA Database/Gene Librar
  • CRISPR Plasmid
  • Human Stem Cells
  • Genetically Modified Organisms/Crops
  • Cell Line Engineering
Segment by Application
  • Biotechnology Companies
  • Pharmaceutical Companies
  • Academic Institutes
  • Research and Development Institutes
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Thermo Fisher Scientific, Editas Medicine, Caribou Biosciences, CRISPR therapeutics, Intellia therapeutics, Inc., Cellectis, Horizon Discovery Plc, Sigma Aldrich, Precision Biosciences, Genscript, Sangamo Biosciences Inc., Lonza Group Limited, Integrated DNA Technologies, New England Biolabs, Origene Technologies
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on.
  • Chapter 2: Revenue of CRISPR and CRISPR-Associated (Cas) Genes in global and regional level.
  • Chapter 3: Detailed analysis of CRISPR and CRISPR-Associated (Cas) Genes company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, CRISPR and CRISPR-Associated (Cas) Genes revenue, gross margin, and recent development, etc.
  • Chapter 5: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 6: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 7: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
  • Chapter 8: Europe by Type, by Application and by country, revenue for each segment.
  • Chapter 9: Asia Pacific by Type, by Application and by region, revenue for each segment.
  • Chapter 10: Latin America by Type, by Application and by country, revenue for each segment.
  • Chapter 11: Middle East and Africa, by Type, by Application and by country, revenue for each segment.
  • Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
  • Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 14: Research Findings and Conclusion

FAQ for this report

What is the market share of major companies in CRISPR and CRISPR-Associated (Cas) Genes Market?

Ans: Thermo Fisher Scientific, Editas Medicine, Caribou Biosciences, CRISPR therapeutics and Intellia therapeutics, Inc. are the top 5 players of CRISPR and CRISPR-Associated (Cas) Genes, with about 63% market shares.

What is the CRISPR and CRISPR-Associated (Cas) Genes Market share by region?

Ans: Among them, North America region accounted for more than 45% of the total market of global CRISPR And CRISPR-Associated (Cas) Genes.

Who are the main players in the CRISPR and CRISPR-Associated (Cas) Genes Market report?

Ans: The main players in the CRISPR and CRISPR-Associated (Cas) Genes Market are Thermo Fisher Scientific, Editas Medicine, Caribou Biosciences, CRISPR therapeutics, Intellia therapeutics, Inc., Cellectis, Horizon Discovery Plc, Sigma Aldrich, Precision Biosciences, Genscript, Sangamo Biosciences Inc., Lonza Group Limited, Integrated DNA Technologies, New England Biolabs, Origene Technologies

What are the Application segmentation covered in the CRISPR and CRISPR-Associated (Cas) Genes Market report?

Ans: The Applications covered in the CRISPR and CRISPR-Associated (Cas) Genes Market report are Biotechnology Companies, Pharmaceutical Companies, Academic Institutes, Research and Development Institutes

What are the Type segmentation covered in the CRISPR and CRISPR-Associated (Cas) Genes Market report?

Ans: The Types covered in the CRISPR and CRISPR-Associated (Cas) Genes Market report are Genome Editing, Genetic engineering, gRNA Database/Gene Librar, CRISPR Plasmid, Human Stem Cells, Genetically Modified Organisms/Crops, Cell Line Engineering

1 Study Coverage
1.1 CRISPR and CRISPR-Associated (Cas) Genes Product Introduction
1.2 Market by Type
1.2.1 Global CRISPR and CRISPR-Associated (Cas) Genes Market Size Growth Rate by Type (2020 VS 2024 VS 2031)
1.2.2 Genome Editing
1.2.3 Genetic engineering
1.2.4 gRNA Database/Gene Librar
1.2.5 CRISPR Plasmid
1.2.6 Human Stem Cells
1.2.7 Genetically Modified Organisms/Crops
1.2.8 Cell Line Engineering
1.3 Market by Application
1.3.1 Global CRISPR and CRISPR-Associated (Cas) Genes Market Size Growth Rate by Application (2020 VS 2024 VS 2031)
1.3.2 Biotechnology Companies
1.3.3 Pharmaceutical Companies
1.3.4 Academic Institutes
1.3.5 Research and Development Institutes
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global CRISPR and CRISPR-Associated (Cas) Genes Market Size Estimates and Forecasts
2.2 CRISPR and CRISPR-Associated (Cas) Genes Market Size by Region: 2024 Versus 2031
2.2.1 Global CRISPR and CRISPR-Associated (Cas) Genes Revenue by Region: 2020-2025
2.2.2 Global CRISPR and CRISPR-Associated (Cas) Genes Revenue Forecast by Region (2026-2031)
2.2.3 Global CRISPR and CRISPR-Associated (Cas) Genes Revenue Market Share by Region (2020-2031)
3 Market Segments
3.1 Breakdown Data by Type
3.1.1 Global CRISPR and CRISPR-Associated (Cas) Genes Revenue by Type (2020-2031)
3.1.2 Global CRISPR and CRISPR-Associated (Cas) Genes Revenue Market Share by Type (2020-2031)
3.2 Breakdown Data by Application
3.2.1 Global CRISPR and CRISPR-Associated (Cas) Genes Revenue by Application (2020-2031)
3.2.2 Global CRISPR and CRISPR-Associated (Cas) Genes Revenue Market Share by Application (2020-2031)
3.3 by Type and by Application Crossing Analysis
3.3.1 Genome Editing of CRISPR and CRISPR-Associated (Cas) Genes Revenue Market Share by Application
3.3.2 Genetic engineering of CRISPR and CRISPR-Associated (Cas) Genes Revenue Market Share by Application
3.3.3 gRNA Database/Gene Librar of CRISPR and CRISPR-Associated (Cas) Genes Revenue Market Share by Application
3.3.4 CRISPR Plasmid of CRISPR and CRISPR-Associated (Cas) Genes Revenue Market Share by Application
3.3.5 Human Stem Cells of CRISPR and CRISPR-Associated (Cas) Genes Revenue Market Share by Application
3.3.6 Genetically Modified Organisms/Crops of CRISPR and CRISPR-Associated (Cas) Genes Revenue Market Share by Application
3.3.7 Cell Line Engineering of CRISPR and CRISPR-Associated (Cas) Genes Revenue Market Share by Application
4 Global CRISPR and CRISPR-Associated (Cas) Genes by Company
4.1 Global CRISPR and CRISPR-Associated (Cas) Genes Revenue by Company (2020-2025)
4.2 Global CRISPR and CRISPR-Associated (Cas) Genes Revenue Share by Company (2020-2025)
4.3 Competitive Landscape
4.3.1 Key CRISPR and CRISPR-Associated (Cas) Genes Companies around the World: Ranking by Revenue
4.3.2 Global CRISPR and CRISPR-Associated (Cas) Genes Market Concentration Ratio (CR5 and HHI) & (2020-2025)
4.3.3 Global CRISPR and CRISPR-Associated (Cas) Genes Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.4 Global CRISPR and CRISPR-Associated (Cas) Genes Companies Headquarters & Product Type
4.4.1 Global CRISPR and CRISPR-Associated (Cas) Genes Companies Headquarters
4.4.2 Date of International Companies Enter into CRISPR and CRISPR-Associated (Cas) Genes Market
4.4.3 Global CRISPR and CRISPR-Associated (Cas) Genes Companies Product & Service
4.4.4 Genome Editing Revenue Market Share of CRISPR and CRISPR-Associated (Cas) Genes by Company
4.4.5 Genetic engineering Revenue Market Share of CRISPR and CRISPR-Associated (Cas) Genes by Company
4.4.6 gRNA Database/Gene Librar Revenue Market Share of CRISPR and CRISPR-Associated (Cas) Genes by Company
4.4.7 CRISPR Plasmid Revenue Market Share of CRISPR and CRISPR-Associated (Cas) Genes by Company
4.4.8 Human Stem Cells Revenue Market Share of CRISPR and CRISPR-Associated (Cas) Genes by Company
4.4.9 Genetically Modified Organisms/Crops Revenue Market Share of CRISPR and CRISPR-Associated (Cas) Genes by Company
4.4.10 Cell Line Engineering Revenue Market Share of CRISPR and CRISPR-Associated (Cas) Genes by Company
4.5 Global CRISPR and CRISPR-Associated (Cas) Genes Mergers & Acquisitions, Expansion Plans
5 Company Profiles
5.1 Thermo Fisher Scientific
5.1.1 Thermo Fisher Scientific Corporation Information
5.1.2 Thermo Fisher Scientific Description, Business Overview
5.1.3 Thermo Fisher Scientific CRISPR and CRISPR-Associated (Cas) Genes Products Offered
5.1.4 Thermo Fisher Scientific CRISPR and CRISPR-Associated (Cas) Genes Revenue and Gross Margin (2020-2025)
5.1.5 Thermo Fisher Scientific CRISPR and CRISPR-Associated (Cas) Genes Revenue by Product in 2024
5.1.6 Thermo Fisher Scientific CRISPR and CRISPR-Associated (Cas) Genes Revenue by Application in 2024
5.1.7 Thermo Fisher Scientific CRISPR and CRISPR-Associated (Cas) Genes Revenue by Geographic Area in 2024
5.1.8 Thermo Fisher Scientific Recent Developments
5.2 Editas Medicine
5.2.1 Editas Medicine Corporation Information
5.2.2 Editas Medicine Description, Business Overview
5.2.3 Editas Medicine CRISPR and CRISPR-Associated (Cas) Genes Products Offered
5.2.4 Editas Medicine CRISPR and CRISPR-Associated (Cas) Genes Revenue and Gross Margin (2020-2025)
5.2.5 Editas Medicine CRISPR and CRISPR-Associated (Cas) Genes Revenue by Product in 2024
5.2.6 Editas Medicine CRISPR and CRISPR-Associated (Cas) Genes Revenue by Application in 2024
5.2.7 Editas Medicine CRISPR and CRISPR-Associated (Cas) Genes Revenue by Geographic Area in 2024
5.2.8 Editas Medicine Recent Developments
5.3 Caribou Biosciences
5.3.1 Caribou Biosciences Corporation Information
5.3.2 Caribou Biosciences Description, Business Overview
5.3.3 Caribou Biosciences CRISPR and CRISPR-Associated (Cas) Genes Products Offered
5.3.4 Caribou Biosciences CRISPR and CRISPR-Associated (Cas) Genes Revenue and Gross Margin (2020-2025)
5.3.5 Caribou Biosciences CRISPR and CRISPR-Associated (Cas) Genes Revenue by Product in 2024
5.3.6 Caribou Biosciences CRISPR and CRISPR-Associated (Cas) Genes Revenue by Application in 2024
5.3.7 Caribou Biosciences CRISPR and CRISPR-Associated (Cas) Genes Revenue by Geographic Area in 2024
5.3.8 Caribou Biosciences Recent Developments
5.4 CRISPR therapeutics
5.4.1 CRISPR therapeutics Corporation Information
5.4.2 CRISPR therapeutics Description, Business Overview
5.4.3 CRISPR therapeutics CRISPR and CRISPR-Associated (Cas) Genes Products Offered
5.4.4 CRISPR therapeutics CRISPR and CRISPR-Associated (Cas) Genes Revenue and Gross Margin (2020-2025)
5.4.5 CRISPR therapeutics CRISPR and CRISPR-Associated (Cas) Genes Revenue by Product in 2024
5.4.6 CRISPR therapeutics CRISPR and CRISPR-Associated (Cas) Genes Revenue by Application in 2024
5.4.7 CRISPR therapeutics CRISPR and CRISPR-Associated (Cas) Genes Revenue by Geographic Area in 2024
5.4.8 CRISPR therapeutics Recent Developments
5.5 Intellia therapeutics, Inc.
5.5.1 Intellia therapeutics, Inc. Corporation Information
5.5.2 Intellia therapeutics, Inc. Description, Business Overview
5.5.3 Intellia therapeutics, Inc. CRISPR and CRISPR-Associated (Cas) Genes Products Offered
5.5.4 Intellia therapeutics, Inc. CRISPR and CRISPR-Associated (Cas) Genes Revenue and Gross Margin (2020-2025)
5.5.5 Intellia therapeutics, Inc. CRISPR and CRISPR-Associated (Cas) Genes Revenue by Product in 2024
5.5.6 Intellia therapeutics, Inc. CRISPR and CRISPR-Associated (Cas) Genes Revenue by Application in 2024
5.5.7 Intellia therapeutics, Inc. CRISPR and CRISPR-Associated (Cas) Genes Revenue by Geographic Area in 2024
5.5.8 Intellia therapeutics, Inc. Recent Developments
5.6 Cellectis
5.6.1 Cellectis Corporation Information
5.6.2 Cellectis Description, Business Overview
5.6.3 Cellectis CRISPR and CRISPR-Associated (Cas) Genes Products Offered
5.6.4 Cellectis CRISPR and CRISPR-Associated (Cas) Genes Revenue and Gross Margin (2020-2025)
5.6.5 Cellectis CRISPR and CRISPR-Associated (Cas) Genes Revenue by Product in 2024
5.6.6 Cellectis CRISPR and CRISPR-Associated (Cas) Genes Revenue by Application in 2024
5.6.7 Cellectis CRISPR and CRISPR-Associated (Cas) Genes Revenue by Geographic Area in 2024
5.6.8 Cellectis Recent Developments
5.7 Horizon Discovery Plc
5.7.1 Horizon Discovery Plc Corporation Information
5.7.2 Horizon Discovery Plc Description, Business Overview
5.7.3 Horizon Discovery Plc CRISPR and CRISPR-Associated (Cas) Genes Products Offered
5.7.4 Horizon Discovery Plc CRISPR and CRISPR-Associated (Cas) Genes Revenue and Gross Margin (2020-2025)
5.7.5 Horizon Discovery Plc CRISPR and CRISPR-Associated (Cas) Genes Revenue by Product in 2024
5.7.6 Horizon Discovery Plc CRISPR and CRISPR-Associated (Cas) Genes Revenue by Application in 2024
5.7.7 Horizon Discovery Plc CRISPR and CRISPR-Associated (Cas) Genes Revenue by Geographic Area in 2024
5.7.8 Horizon Discovery Plc Recent Developments
5.8 Sigma Aldrich
5.8.1 Sigma Aldrich Corporation Information
5.8.2 Sigma Aldrich Description, Business Overview
5.8.3 Sigma Aldrich CRISPR and CRISPR-Associated (Cas) Genes Products Offered
5.8.4 Sigma Aldrich CRISPR and CRISPR-Associated (Cas) Genes Revenue and Gross Margin (2020-2025)
5.8.5 Sigma Aldrich CRISPR and CRISPR-Associated (Cas) Genes Revenue by Product in 2024
5.8.6 Sigma Aldrich CRISPR and CRISPR-Associated (Cas) Genes Revenue by Application in 2024
5.8.7 Sigma Aldrich CRISPR and CRISPR-Associated (Cas) Genes Revenue by Geographic Area in 2024
5.8.8 Sigma Aldrich Recent Developments
5.9 Precision Biosciences
5.9.1 Precision Biosciences Corporation Information
5.9.2 Precision Biosciences Description, Business Overview
5.9.3 Precision Biosciences CRISPR and CRISPR-Associated (Cas) Genes Products Offered
5.9.4 Precision Biosciences CRISPR and CRISPR-Associated (Cas) Genes Revenue and Gross Margin (2020-2025)
5.9.5 Precision Biosciences CRISPR and CRISPR-Associated (Cas) Genes Revenue by Product in 2024
5.9.6 Precision Biosciences CRISPR and CRISPR-Associated (Cas) Genes Revenue by Application in 2024
5.9.7 Precision Biosciences CRISPR and CRISPR-Associated (Cas) Genes Revenue by Geographic Area in 2024
5.9.8 Precision Biosciences Recent Developments
5.10 Genscript
5.10.1 Genscript Corporation Information
5.10.2 Genscript Description, Business Overview
5.10.3 Genscript CRISPR and CRISPR-Associated (Cas) Genes Products Offered
5.10.4 Genscript CRISPR and CRISPR-Associated (Cas) Genes Revenue and Gross Margin (2020-2025)
5.10.5 Genscript CRISPR and CRISPR-Associated (Cas) Genes Revenue by Product in 2024
5.10.6 Genscript CRISPR and CRISPR-Associated (Cas) Genes Revenue by Application in 2024
5.10.7 Genscript CRISPR and CRISPR-Associated (Cas) Genes Revenue by Geographic Area in 2024
5.10.8 Genscript Recent Developments
5.11 Sangamo Biosciences Inc.
5.11.1 Sangamo Biosciences Inc. Corporation Information
5.11.2 Sangamo Biosciences Inc. Description, Business Overview
5.11.3 Sangamo Biosciences Inc. CRISPR and CRISPR-Associated (Cas) Genes Products Offered
5.11.4 Sangamo Biosciences Inc. CRISPR and CRISPR-Associated (Cas) Genes Revenue and Gross Margin (2020-2025)
5.11.5 Sangamo Biosciences Inc. CRISPR and CRISPR-Associated (Cas) Genes Revenue by Product in 2024
5.11.6 Sangamo Biosciences Inc. CRISPR and CRISPR-Associated (Cas) Genes Revenue by Application in 2024
5.11.7 Sangamo Biosciences Inc. CRISPR and CRISPR-Associated (Cas) Genes Revenue by Geographic Area in 2024
5.11.8 Sangamo Biosciences Inc. Recent Developments
5.12 Lonza Group Limited
5.12.1 Lonza Group Limited Corporation Information
5.12.2 Lonza Group Limited Description, Business Overview
5.12.3 Lonza Group Limited CRISPR and CRISPR-Associated (Cas) Genes Products Offered
5.12.4 Lonza Group Limited CRISPR and CRISPR-Associated (Cas) Genes Revenue and Gross Margin (2020-2025)
5.12.5 Lonza Group Limited CRISPR and CRISPR-Associated (Cas) Genes Revenue by Product in 2024
5.12.6 Lonza Group Limited CRISPR and CRISPR-Associated (Cas) Genes Revenue by Application in 2024
5.12.7 Lonza Group Limited CRISPR and CRISPR-Associated (Cas) Genes Revenue by Geographic Area in 2024
5.12.8 Lonza Group Limited Recent Developments
5.13 Integrated DNA Technologies
5.13.1 Integrated DNA Technologies Corporation Information
5.13.2 Integrated DNA Technologies Description, Business Overview
5.13.3 Integrated DNA Technologies CRISPR and CRISPR-Associated (Cas) Genes Products Offered
5.13.4 Integrated DNA Technologies CRISPR and CRISPR-Associated (Cas) Genes Revenue and Gross Margin (2020-2025)
5.13.5 Integrated DNA Technologies CRISPR and CRISPR-Associated (Cas) Genes Revenue by Product in 2024
5.13.6 Integrated DNA Technologies CRISPR and CRISPR-Associated (Cas) Genes Revenue by Application in 2024
5.13.7 Integrated DNA Technologies CRISPR and CRISPR-Associated (Cas) Genes Revenue by Geographic Area in 2024
5.13.8 Integrated DNA Technologies Recent Developments
5.14 New England Biolabs
5.14.1 New England Biolabs Corporation Information
5.14.2 New England Biolabs Description, Business Overview
5.14.3 New England Biolabs CRISPR and CRISPR-Associated (Cas) Genes Products Offered
5.14.4 New England Biolabs CRISPR and CRISPR-Associated (Cas) Genes Revenue and Gross Margin (2020-2025)
5.14.5 New England Biolabs CRISPR and CRISPR-Associated (Cas) Genes Revenue by Product in 2024
5.14.6 New England Biolabs CRISPR and CRISPR-Associated (Cas) Genes Revenue by Application in 2024
5.14.7 New England Biolabs CRISPR and CRISPR-Associated (Cas) Genes Revenue by Geographic Area in 2024
5.14.8 New England Biolabs Recent Developments
5.15 Origene Technologies
5.15.1 Origene Technologies Corporation Information
5.15.2 Origene Technologies Description, Business Overview
5.15.3 Origene Technologies CRISPR and CRISPR-Associated (Cas) Genes Products Offered
5.15.4 Origene Technologies CRISPR and CRISPR-Associated (Cas) Genes Revenue and Gross Margin (2020-2025)
5.15.5 Origene Technologies CRISPR and CRISPR-Associated (Cas) Genes Revenue by Product in 2024
5.15.6 Origene Technologies CRISPR and CRISPR-Associated (Cas) Genes Revenue by Application in 2024
5.15.7 Origene Technologies CRISPR and CRISPR-Associated (Cas) Genes Revenue by Geographic Area in 2024
5.15.8 Origene Technologies Recent Developments
6 North America
6.1 North America CRISPR and CRISPR-Associated (Cas) Genes Market Size YoY Growth 2020-2031
6.2 North America CRISPR and CRISPR-Associated (Cas) Genes Market Facts & Figures by Country (2020-2031)
6.3 North America CRISPR and CRISPR-Associated (Cas) Genes Revenue by Type (2020-2025)
6.4 North America CRISPR and CRISPR-Associated (Cas) Genes Revenue by Application (2020-2025)
7 Asia-Pacific
7.1 Asia-Pacific CRISPR and CRISPR-Associated (Cas) Genes Market Size YoY Growth 2020-2031
7.2 Asia-Pacific CRISPR and CRISPR-Associated (Cas) Genes Market Facts & Figures by Region (2020-2031)
7.3 Asia-Pacific CRISPR and CRISPR-Associated (Cas) Genes Revenue by Type (2020-2025)
7.4 Asia-Pacific CRISPR and CRISPR-Associated (Cas) Genes Revenue by Application (2020-2025)
8 Europe
8.1 Europe CRISPR and CRISPR-Associated (Cas) Genes Market Size YoY Growth 2020-2031
8.2 Europe CRISPR and CRISPR-Associated (Cas) Genes Market Facts & Figures by Country (2020-2031)
8.3 Europe CRISPR and CRISPR-Associated (Cas) Genes Revenue by Type (2020-2025)
8.4 Europe CRISPR and CRISPR-Associated (Cas) Genes Revenue by Application (2020-2025)
9 Latin America
9.1 Latin America CRISPR and CRISPR-Associated (Cas) Genes Market Size YoY Growth 2020-2031
9.2 Latin America CRISPR and CRISPR-Associated (Cas) Genes Market Facts & Figures by Country (2020-2031)
9.3 Latin America CRISPR and CRISPR-Associated (Cas) Genes Revenue by Type (2020-2025)
9.4 Latin America CRISPR and CRISPR-Associated (Cas) Genes Revenue by Application (2020-2025)
10 Middle East and Africa
10.1 Latin America CRISPR and CRISPR-Associated (Cas) Genes Market Size YoY Growth 2020-2031
10.2 Middle East and Africa CRISPR and CRISPR-Associated (Cas) Genes Market Facts & Figures by Country (2020-2031)
10.3 Middle East and Africa CRISPR and CRISPR-Associated (Cas) Genes Revenue by Type (2020-2025)
10.4 Middle East and Africa CRISPR and CRISPR-Associated (Cas) Genes Revenue by Application (2020-2025)
11 Supply Chain and Sales Channel analysis
11.1 CRISPR and CRISPR-Associated (Cas) Genes Supply Chain Analysis
11.2 CRISPR and CRISPR-Associated (Cas) Genes Key Raw Materials and Upstream Suppliers
11.3 CRISPR and CRISPR-Associated (Cas) Genes Clients Analysis
11.4 CRISPR and CRISPR-Associated (Cas) Genes Sales Channel and Sales Model Analysis
11.4.1 CRISPR and CRISPR-Associated (Cas) Genes Distribution Channel Analysis: Indirect Sales VS Direct Sales
11.4.2 CRISPR and CRISPR-Associated (Cas) Genes Distribution Channel Analysis: Online Sales VS Offline Sales
11.4.3 CRISPR and CRISPR-Associated (Cas) Genes Distributors
12 CRISPR and CRISPR-Associated (Cas) Genes Market Dynamics
12.1 CRISPR and CRISPR-Associated (Cas) Genes Industry Trends
12.2 CRISPR and CRISPR-Associated (Cas) Genes Market Drivers
12.3 CRISPR and CRISPR-Associated (Cas) Genes Market Challenges
12.4 CRISPR and CRISPR-Associated (Cas) Genes Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
FEATURED COMPANIES
Thermo Fisher Scientific
Editas Medicine
Caribou Biosciences
CRISPR Therapeutics
Intellia Therapeutics Inc
CELLECTIS
Horizon Discovery Plc
Sigma-aldrich
Precision Biosciences
GenScript
Sangamo BioSciences, Inc.
Lonza Group Limited
Integrated DNA Technologies
New England Biolabs
Origene Technologies
List of Tables
 Table 1. Global CRISPR and CRISPR-Associated (Cas) Genes Market Size Growth Rate (CAGR) by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Global CRISPR and CRISPR-Associated (Cas) Genes Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 3. Global CRISPR and CRISPR-Associated (Cas) Genes Market Size by Region (US$ Million): 2024 VS 2031
 Table 4. Global CRISPR and CRISPR-Associated (Cas) Genes Revenue by Region (2020-2025) & (US$ Million)
 Table 5. Global CRISPR and CRISPR-Associated (Cas) Genes Revenue Forecast by Region (2026-2031) & (US$ Million)
 Table 6. Global CRISPR and CRISPR-Associated (Cas) Genes Revenue by Type (2020-2025) & (US$ Million)
 Table 7. Global CRISPR and CRISPR-Associated (Cas) Genes Revenue Forecast by Type (2026-2031) & (US$ Million)
 Table 8. Global CRISPR and CRISPR-Associated (Cas) Genes Revenue by Application (2020-2025) & (US$ Million)
 Table 9. Global CRISPR and CRISPR-Associated (Cas) Genes Revenue Forecast by Application (2026-2031) & (US$ Million)
 Table 10. CRISPR and CRISPR-Associated (Cas) Genes Revenue by Company (2020-2025) & (US$ Million)
 Table 11. CRISPR and CRISPR-Associated (Cas) Genes Revenue Share by Company (2020-2025)
 Table 12. Ranking of Global Top CRISPR and CRISPR-Associated (Cas) Genes Players by Revenue (US$ Million) in 2024
 Table 13. Global CRISPR and CRISPR-Associated (Cas) Genes Companies Market Concentration Ratio (CR5 and HHI) & (2020-2025)
 Table 14. Global CRISPR and CRISPR-Associated (Cas) Genes by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CRISPR and CRISPR-Associated (Cas) Genes as of 2024)
 Table 15. Global CRISPR and CRISPR-Associated (Cas) Genes Companies Headquarters
 Table 16. Date of International Companies Enter into CRISPR and CRISPR-Associated (Cas) Genes Market
 Table 17. Global CRISPR and CRISPR-Associated (Cas) Genes Companies Product & Service
 Table 18. Global CRISPR and CRISPR-Associated (Cas) Genes Mergers & Acquisitions, Expansion Plans
 Table 19. Thermo Fisher Scientific Corporation Information
 Table 20. Thermo Fisher Scientific Description and Business Overview
 Table 21. Thermo Fisher Scientific CRISPR and CRISPR-Associated (Cas) Genes Product
 Table 22. Thermo Fisher Scientific CRISPR and CRISPR-Associated (Cas) Genes Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 23. Thermo Fisher Scientific Revenue Proportion of CRISPR and CRISPR-Associated (Cas) Genes by Product in 2024
 Table 24. Thermo Fisher Scientific Revenue Proportion of CRISPR and CRISPR-Associated (Cas) Genes by Application in 2024
 Table 25. Thermo Fisher Scientific Revenue Proportion of CRISPR and CRISPR-Associated (Cas) Genes by Geographic Area in 2024
 Table 26. Thermo Fisher Scientific Recent Developments
 Table 27. Editas Medicine Corporation Information
 Table 28. Editas Medicine Description and Business Overview
 Table 29. Editas Medicine CRISPR and CRISPR-Associated (Cas) Genes Product
 Table 30. Editas Medicine CRISPR and CRISPR-Associated (Cas) Genes Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 31. Editas Medicine Revenue Proportion of CRISPR and CRISPR-Associated (Cas) Genes by Product in 2024
 Table 32. Editas Medicine Revenue Proportion of CRISPR and CRISPR-Associated (Cas) Genes by Application in 2024
 Table 33. Editas Medicine Revenue Proportion of CRISPR and CRISPR-Associated (Cas) Genes by Geographic Area in 2024
 Table 34. Editas Medicine Recent Developments
 Table 35. Caribou Biosciences Corporation Information
 Table 36. Caribou Biosciences Description and Business Overview
 Table 37. Caribou Biosciences CRISPR and CRISPR-Associated (Cas) Genes Product
 Table 38. Caribou Biosciences CRISPR and CRISPR-Associated (Cas) Genes Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 39. Caribou Biosciences Revenue Proportion of CRISPR and CRISPR-Associated (Cas) Genes by Product in 2024
 Table 40. Caribou Biosciences Revenue Proportion of CRISPR and CRISPR-Associated (Cas) Genes by Application in 2024
 Table 41. Caribou Biosciences Revenue Proportion of CRISPR and CRISPR-Associated (Cas) Genes by Geographic Area in 2024
 Table 42. Caribou Biosciences Recent Developments
 Table 43. CRISPR therapeutics Corporation Information
 Table 44. CRISPR therapeutics Description and Business Overview
 Table 45. CRISPR therapeutics CRISPR and CRISPR-Associated (Cas) Genes Product
 Table 46. CRISPR therapeutics CRISPR and CRISPR-Associated (Cas) Genes Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 47. CRISPR therapeutics Revenue Proportion of CRISPR and CRISPR-Associated (Cas) Genes by Product in 2024
 Table 48. CRISPR therapeutics Revenue Proportion of CRISPR and CRISPR-Associated (Cas) Genes by Application in 2024
 Table 49. CRISPR therapeutics Revenue Proportion of CRISPR and CRISPR-Associated (Cas) Genes by Geographic Area in 2024
 Table 50. CRISPR therapeutics Recent Developments
 Table 51. Intellia therapeutics, Inc. Corporation Information
 Table 52. Intellia therapeutics, Inc. Description and Business Overview
 Table 53. Intellia therapeutics, Inc. CRISPR and CRISPR-Associated (Cas) Genes Product
 Table 54. Intellia therapeutics, Inc. CRISPR and CRISPR-Associated (Cas) Genes Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 55. Intellia therapeutics, Inc. Revenue Proportion of CRISPR and CRISPR-Associated (Cas) Genes by Product in 2024
 Table 56. Intellia therapeutics, Inc. Revenue Proportion of CRISPR and CRISPR-Associated (Cas) Genes by Application in 2024
 Table 57. Intellia therapeutics, Inc. Revenue Proportion of CRISPR and CRISPR-Associated (Cas) Genes by Geographic Area in 2024
 Table 58. Intellia therapeutics, Inc. Recent Developments
 Table 59. Cellectis Corporation Information
 Table 60. Cellectis Description and Business Overview
 Table 61. Cellectis CRISPR and CRISPR-Associated (Cas) Genes Product
 Table 62. Cellectis CRISPR and CRISPR-Associated (Cas) Genes Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 63. Cellectis Revenue Proportion of CRISPR and CRISPR-Associated (Cas) Genes by Product in 2024
 Table 64. Cellectis Revenue Proportion of CRISPR and CRISPR-Associated (Cas) Genes by Application in 2024
 Table 65. Cellectis Revenue Proportion of CRISPR and CRISPR-Associated (Cas) Genes by Geographic Area in 2024
 Table 66. Cellectis Recent Developments
 Table 67. Horizon Discovery Plc Corporation Information
 Table 68. Horizon Discovery Plc Description and Business Overview
 Table 69. Horizon Discovery Plc CRISPR and CRISPR-Associated (Cas) Genes Product
 Table 70. Horizon Discovery Plc CRISPR and CRISPR-Associated (Cas) Genes Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 71. Horizon Discovery Plc Revenue Proportion of CRISPR and CRISPR-Associated (Cas) Genes by Product in 2024
 Table 72. Horizon Discovery Plc Revenue Proportion of CRISPR and CRISPR-Associated (Cas) Genes by Application in 2024
 Table 73. Horizon Discovery Plc Revenue Proportion of CRISPR and CRISPR-Associated (Cas) Genes by Geographic Area in 2024
 Table 74. Horizon Discovery Plc Recent Developments
 Table 75. Sigma Aldrich Corporation Information
 Table 76. Sigma Aldrich Description and Business Overview
 Table 77. Sigma Aldrich CRISPR and CRISPR-Associated (Cas) Genes Product
 Table 78. Sigma Aldrich CRISPR and CRISPR-Associated (Cas) Genes Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 79. Sigma Aldrich Revenue Proportion of CRISPR and CRISPR-Associated (Cas) Genes by Product in 2024
 Table 80. Sigma Aldrich Revenue Proportion of CRISPR and CRISPR-Associated (Cas) Genes by Application in 2024
 Table 81. Sigma Aldrich Revenue Proportion of CRISPR and CRISPR-Associated (Cas) Genes by Geographic Area in 2024
 Table 82. Sigma Aldrich Recent Developments
 Table 83. Precision Biosciences Corporation Information
 Table 84. Precision Biosciences Description and Business Overview
 Table 85. Precision Biosciences CRISPR and CRISPR-Associated (Cas) Genes Product
 Table 86. Precision Biosciences CRISPR and CRISPR-Associated (Cas) Genes Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 87. Precision Biosciences Revenue Proportion of CRISPR and CRISPR-Associated (Cas) Genes by Product in 2024
 Table 88. Precision Biosciences Revenue Proportion of CRISPR and CRISPR-Associated (Cas) Genes by Application in 2024
 Table 89. Precision Biosciences Revenue Proportion of CRISPR and CRISPR-Associated (Cas) Genes by Geographic Area in 2024
 Table 90. Precision Biosciences Recent Developments
 Table 91. Genscript Corporation Information
 Table 92. Genscript Description and Business Overview
 Table 93. Genscript CRISPR and CRISPR-Associated (Cas) Genes Product
 Table 94. Genscript CRISPR and CRISPR-Associated (Cas) Genes Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 95. Genscript Revenue Proportion of CRISPR and CRISPR-Associated (Cas) Genes by Product in 2024
 Table 96. Genscript Revenue Proportion of CRISPR and CRISPR-Associated (Cas) Genes by Application in 2024
 Table 97. Genscript Revenue Proportion of CRISPR and CRISPR-Associated (Cas) Genes by Geographic Area in 2024
 Table 98. Genscript Recent Developments
 Table 99. Sangamo Biosciences Inc. Corporation Information
 Table 100. Sangamo Biosciences Inc. Description and Business Overview
 Table 101. Sangamo Biosciences Inc. CRISPR and CRISPR-Associated (Cas) Genes Product
 Table 102. Sangamo Biosciences Inc. CRISPR and CRISPR-Associated (Cas) Genes Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 103. Sangamo Biosciences Inc. Revenue Proportion of CRISPR and CRISPR-Associated (Cas) Genes by Product in 2024
 Table 104. Sangamo Biosciences Inc. Revenue Proportion of CRISPR and CRISPR-Associated (Cas) Genes by Application in 2024
 Table 105. Sangamo Biosciences Inc. Revenue Proportion of CRISPR and CRISPR-Associated (Cas) Genes by Geographic Area in 2024
 Table 106. Sangamo Biosciences Inc. Recent Developments
 Table 107. Lonza Group Limited Corporation Information
 Table 108. Lonza Group Limited Description and Business Overview
 Table 109. Lonza Group Limited CRISPR and CRISPR-Associated (Cas) Genes Product
 Table 110. Lonza Group Limited CRISPR and CRISPR-Associated (Cas) Genes Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 111. Lonza Group Limited Revenue Proportion of CRISPR and CRISPR-Associated (Cas) Genes by Product in 2024
 Table 112. Lonza Group Limited Revenue Proportion of CRISPR and CRISPR-Associated (Cas) Genes by Application in 2024
 Table 113. Lonza Group Limited Revenue Proportion of CRISPR and CRISPR-Associated (Cas) Genes by Geographic Area in 2024
 Table 114. Lonza Group Limited Recent Developments
 Table 115. Integrated DNA Technologies Corporation Information
 Table 116. Integrated DNA Technologies Description and Business Overview
 Table 117. Integrated DNA Technologies CRISPR and CRISPR-Associated (Cas) Genes Product
 Table 118. Integrated DNA Technologies CRISPR and CRISPR-Associated (Cas) Genes Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 119. Integrated DNA Technologies Revenue Proportion of CRISPR and CRISPR-Associated (Cas) Genes by Product in 2024
 Table 120. Integrated DNA Technologies Revenue Proportion of CRISPR and CRISPR-Associated (Cas) Genes by Application in 2024
 Table 121. Integrated DNA Technologies Revenue Proportion of CRISPR and CRISPR-Associated (Cas) Genes by Geographic Area in 2024
 Table 122. Integrated DNA Technologies Recent Developments
 Table 123. New England Biolabs Corporation Information
 Table 124. New England Biolabs Description and Business Overview
 Table 125. New England Biolabs CRISPR and CRISPR-Associated (Cas) Genes Product
 Table 126. New England Biolabs CRISPR and CRISPR-Associated (Cas) Genes Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 127. New England Biolabs Revenue Proportion of CRISPR and CRISPR-Associated (Cas) Genes by Product in 2024
 Table 128. New England Biolabs Revenue Proportion of CRISPR and CRISPR-Associated (Cas) Genes by Application in 2024
 Table 129. New England Biolabs Revenue Proportion of CRISPR and CRISPR-Associated (Cas) Genes by Geographic Area in 2024
 Table 130. New England Biolabs Recent Developments
 Table 131. Origene Technologies Corporation Information
 Table 132. Origene Technologies Description and Business Overview
 Table 133. Origene Technologies CRISPR and CRISPR-Associated (Cas) Genes Product
 Table 134. Origene Technologies CRISPR and CRISPR-Associated (Cas) Genes Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 135. Origene Technologies Revenue Proportion of CRISPR and CRISPR-Associated (Cas) Genes by Product in 2024
 Table 136. Origene Technologies Revenue Proportion of CRISPR and CRISPR-Associated (Cas) Genes by Application in 2024
 Table 137. Origene Technologies Revenue Proportion of CRISPR and CRISPR-Associated (Cas) Genes by Geographic Area in 2024
 Table 138. Origene Technologies Recent Developments
 Table 139. North America CRISPR and CRISPR-Associated (Cas) Genes Revenue by Country (2020-2025) & (US$ Million)
 Table 140. North America CRISPR and CRISPR-Associated (Cas) Genes Revenue by Country (2026-2031) & (US$ Million)
 Table 141. North America CRISPR and CRISPR-Associated (Cas) Genes Revenue by Type (2020-2025) & (US$ Million)
 Table 142. North America CRISPR and CRISPR-Associated (Cas) Genes Revenue by Application (2020-2025) & (US$ Million)
 Table 143. Asia-Pacific CRISPR and CRISPR-Associated (Cas) Genes Revenue by Region (2020-2025) & (US$ Million)
 Table 144. Asia-Pacific CRISPR and CRISPR-Associated (Cas) Genes Revenue by Region (2026-2031) & (US$ Million)
 Table 145. Asia-Pacific CRISPR and CRISPR-Associated (Cas) Genes Revenue by Type (2020-2025) & (US$ Million)
 Table 146. Asia-Pacific CRISPR and CRISPR-Associated (Cas) Genes Revenue by Application (2020-2025) & (US$ Million)
 Table 147. Europe CRISPR and CRISPR-Associated (Cas) Genes Revenue by Country (2020-2025) & (US$ Million)
 Table 148. Europe CRISPR and CRISPR-Associated (Cas) Genes Revenue by Country (2026-2031) & (US$ Million)
 Table 149. Europe CRISPR and CRISPR-Associated (Cas) Genes Revenue by Type (2020-2025) & (US$ Million)
 Table 150. Europe CRISPR and CRISPR-Associated (Cas) Genes Revenue by Application (2020-2025) & (US$ Million)
 Table 151. Latin America CRISPR and CRISPR-Associated (Cas) Genes Revenue by Country (2020-2025) & (US$ Million)
 Table 152. Latin America CRISPR and CRISPR-Associated (Cas) Genes Revenue by Country (2026-2031) & (US$ Million)
 Table 153. Latin America CRISPR and CRISPR-Associated (Cas) Genes Revenue by Type (2020-2025) & (US$ Million)
 Table 154. Latin America CRISPR and CRISPR-Associated (Cas) Genes Revenue by Application (2020-2025) & (US$ Million)
 Table 155. Middle East and Africa CRISPR and CRISPR-Associated (Cas) Genes Revenue by Country (2020-2025) & (US$ Million)
 Table 156. Middle East and Africa CRISPR and CRISPR-Associated (Cas) Genes Revenue by Country (2026-2031) & (US$ Million)
 Table 157. Middle East and Africa CRISPR and CRISPR-Associated (Cas) Genes Revenue by Type (2020-2025) & (US$ Million)
 Table 158. Middle East and Africa CRISPR and CRISPR-Associated (Cas) Genes Revenue by Application (2020-2025) & (US$ Million)
 Table 159. CRISPR and CRISPR-Associated (Cas) Genes Key Raw Materials, Industry Status and Trend
 Table 160. CRISPR and CRISPR-Associated (Cas) Genes Key Raw Materials and Upstream Suppliers
 Table 161. CRISPR and CRISPR-Associated (Cas) Genes Clients Status and Trend
 Table 162. CRISPR and CRISPR-Associated (Cas) Genes Typical Clients
 Table 163. CRISPR and CRISPR-Associated (Cas) Genes Distributors
 Table 164. CRISPR and CRISPR-Associated (Cas) Genes Market Trends
 Table 165. CRISPR and CRISPR-Associated (Cas) Genes Market Drivers
 Table 166. CRISPR and CRISPR-Associated (Cas) Genes Market Challenges
 Table 167. CRISPR and CRISPR-Associated (Cas) Genes Market Restraints
 Table 168. Research Programs/Design for This Report
 Table 169. Key Data Information from Secondary Sources
 Table 170. Key Data Information from Primary Sources


List of Figures
 Figure 1. CRISPR and CRISPR-Associated (Cas) Genes Product Picture
 Figure 2. Global CRISPR and CRISPR-Associated (Cas) Genes Market Size by Type (US$ Million): 2020 VS 2024 VS 2031
 Figure 3. Global CRISPR and CRISPR-Associated (Cas) Genes Revenue Market Share by Type in 2024 & 2031
 Figure 4. Genome Editing Product Picture
 Figure 5. Genetic engineering Product Picture
 Figure 6. gRNA Database/Gene Librar Product Picture
 Figure 7. CRISPR Plasmid Product Picture
 Figure 8. Human Stem Cells Product Picture
 Figure 9. Genetically Modified Organisms/Crops Product Picture
 Figure 10. Cell Line Engineering Product Picture
 Figure 11. Global CRISPR and CRISPR-Associated (Cas) Genes Market Size by Application (US$ Million): 2020 VS 2024 VS 2031
 Figure 12. Global CRISPR and CRISPR-Associated (Cas) Genes Revenue Market Share by Application in 2024 & 2031
 Figure 13. Biotechnology Companies
 Figure 14. Pharmaceutical Companies
 Figure 15. Academic Institutes
 Figure 16. Research and Development Institutes
 Figure 17. CRISPR and CRISPR-Associated (Cas) Genes Report Years Considered
 Figure 18. Global CRISPR and CRISPR-Associated (Cas) Genes Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 19. Global CRISPR and CRISPR-Associated (Cas) Genes Market Size (2020-2031) & (US$ Million)
 Figure 20. Global CRISPR and CRISPR-Associated (Cas) Genes Market Size Market Share by Region: 2024 Versus 2031
 Figure 21. Global CRISPR and CRISPR-Associated (Cas) Genes Revenue Market Share by Region (2020-2031)
 Figure 22. Global CRISPR and CRISPR-Associated (Cas) Genes Revenue Market Share Forecast by Type (2020-2031)
 Figure 23. Global CRISPR and CRISPR-Associated (Cas) Genes Revenue Market Share Forecast by Application (2020-2031)
 Figure 24. Genome Editing of CRISPR and CRISPR-Associated (Cas) Genes Revenue Market Share by Application, 2024 VS 2031
 Figure 25. Genetic engineering of CRISPR and CRISPR-Associated (Cas) Genes Revenue Market Share by Application, 2024 VS 2031
 Figure 26. gRNA Database/Gene Librar of CRISPR and CRISPR-Associated (Cas) Genes Revenue Market Share by Application, 2024 VS 2031
 Figure 27. CRISPR Plasmid of CRISPR and CRISPR-Associated (Cas) Genes Revenue Market Share by Application, 2024 VS 2031
 Figure 28. Human Stem Cells of CRISPR and CRISPR-Associated (Cas) Genes Revenue Market Share by Application, 2024 VS 2031
 Figure 29. Genetically Modified Organisms/Crops of CRISPR and CRISPR-Associated (Cas) Genes Revenue Market Share by Application, 2024 VS 2031
 Figure 30. Cell Line Engineering of CRISPR and CRISPR-Associated (Cas) Genes Revenue Market Share by Application, 2024 VS 2031
 Figure 31. CRISPR and CRISPR-Associated (Cas) Genes Revenue Share by Company (2024)
 Figure 32. CRISPR and CRISPR-Associated (Cas) Genes Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 33. Genome Editing Revenue Proportion by Company in 2024
 Figure 34. Genetic engineering Revenue Proportion by Company in 2024
 Figure 35. gRNA Database/Gene Librar Revenue Proportion by Company in 2024
 Figure 36. CRISPR Plasmid Revenue Proportion by Company in 2024
 Figure 37. Human Stem Cells Revenue Proportion by Company in 2024
 Figure 38. Genetically Modified Organisms/Crops Revenue Proportion by Company in 2024
 Figure 39. Cell Line Engineering Revenue Proportion by Company in 2024
 Figure 40. North America CRISPR and CRISPR-Associated (Cas) Genes Revenue 2020-2031 (US$ Million)
 Figure 41. North America CRISPR and CRISPR-Associated (Cas) Genes Revenue Market Share by Type (2020-2025)
 Figure 42. North America CRISPR and CRISPR-Associated (Cas) Genes Revenue Market Share by Application (2020-2025)
 Figure 43. Asia-Pacific CRISPR and CRISPR-Associated (Cas) Genes Revenue 2020-2031 (US$ Million)
 Figure 44. Asia-Pacific CRISPR and CRISPR-Associated (Cas) Genes Revenue Market Share by Region (2020-2031)
 Figure 45. Asia-Pacific CRISPR and CRISPR-Associated (Cas) Genes Revenue Market Share by Type (2020-2025)
 Figure 46. Asia-Pacific CRISPR and CRISPR-Associated (Cas) Genes Revenue Market Share by Application (2020-2025)
 Figure 47. Europe CRISPR and CRISPR-Associated (Cas) Genes Revenue Growth Rate 2020-2031 (US$ Million)
 Figure 48. Europe CRISPR and CRISPR-Associated (Cas) Genes Revenue Market Share by Country (2020-2031)
 Figure 49. Europe CRISPR and CRISPR-Associated (Cas) Genes Revenue Market Share by Type (2020-2025)
 Figure 50. Europe CRISPR and CRISPR-Associated (Cas) Genes Revenue Market Share by Application (2020-2025)
 Figure 51. Latin America CRISPR and CRISPR-Associated (Cas) Genes Revenue Growth Rate 2020-2031 (US$ Million)
 Figure 52. Latin America CRISPR and CRISPR-Associated (Cas) Genes Revenue Market Share by Country (2020-2031)
 Figure 53. Latin America CRISPR and CRISPR-Associated (Cas) Genes Revenue Market Share by Type (2020-2025)
 Figure 54. Latin America CRISPR and CRISPR-Associated (Cas) Genes Revenue Market Share by Application (2020-2025)
 Figure 55. Middle East and Africa CRISPR and CRISPR-Associated (Cas) Genes Revenue Growth Rate 2020-2031 (US$ Million)
 Figure 56. Middle East and Africa CRISPR and CRISPR-Associated (Cas) Genes Revenue Market Share by Country (2020-2031)
 Figure 57. Middle East and Africa CRISPR and CRISPR-Associated (Cas) Genes Revenue Market Share by Type (2020-2025)
 Figure 58. Middle East and Africa CRISPR and CRISPR-Associated (Cas) Genes Revenue Market Share by Application (2020-2025)
 Figure 59. CRISPR and CRISPR-Associated (Cas) Genes Supply Chain (Upstream and Downstream Market)
 Figure 60. Global Production Market Share of CRISPR and CRISPR-Associated (Cas) Genes Raw Materials by Region in 2024
 Figure 61. CRISPR and CRISPR-Associated (Cas) Genes Distribution Channels
 Figure 62. Global CRISPR and CRISPR-Associated (Cas) Genes Percentage 2020-2031: Indirect Sales VS Direct Sales
 Figure 63. Global CRISPR and CRISPR-Associated (Cas) Genes Percentage 2020-2031: Online Sales VS Offline Sales
 Figure 64. Bottom-up and Top-down Approaches for This Report
 Figure 65. Data Triangulation
 Figure 66. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$5900

This license allows only one user to access the PDF.
Electronic (PDF)

$8850

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$11800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Samsung SD

SIMILAR REPORTS

CRISPR And CRISPR Associated Genes Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global CRISPR Cas Genes Market Research Report 2024
Global CRISPR associated Nucleases Market Research Report 2024
Global CRISPER associated Nucleases Market Research Report 2024
CRISPR in Agriculture Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global CRISPR Kit Market Research Report 2024
Global CRISPR Gene Editing Market Research Report 2024
Global CRISPR Genome Editing Market Insights Forecast to 2030
Global Plant Breeding and CRISPR Plants Market Insights Forecast to 2030
Global CRISPR Gene Editing Tools Market Research Report 2024
Global CRISPR Based Therapeutics Market Research Report 2024
Prime Editing Technology Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global CRISPR Knockout Cell Lines Market Research Report 2025
Global CRISPR Cell Line Development Market Research Report 2024
Global CRISPR Cas9 Gene Editing Service Market Research Report 2025
Global CRISPR Cas9 Nuclease Market Research Report 2024
Global CRISPR Gene Testing and Diagnostics Market Research Report 2024
Global Crispr Genomic Cure Market Research Report 2024
Global CRISPR Gene Detection and Diagnostic Market Research Report 2024
Global Gene Editing Tools Market Insights Forecast to 2030
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions